Primary adrenal insufficiency – Diagnostics – Overview of Information and Clinical Research

Primary adrenal insufficiency, also known as Addison’s disease, is a rare but serious condition that requires careful diagnosis to identify properly and distinguish from other similar disorders. Early detection through appropriate testing can make the difference between timely treatment and potentially life-threatening complications.

Who Should Undergo Diagnostics and When to Seek Testing

Finding out if you have primary adrenal insufficiency can be challenging because the symptoms develop gradually and often feel very general. People typically notice extreme tiredness that worsens over time, unexplained weight loss, nausea, and dizziness when standing up. These symptoms can easily be mistaken for many other conditions, which is why doctors need to maintain a high level of suspicion to catch this disease early.^[1]

You should consider seeking medical evaluation if you experience a combination of steadily worsening fatigue, loss of appetite, weight loss, and low blood pressure that causes lightheadedness. Another important sign is unusual darkening of your skin, particularly around scars, skin creases, and on your gums. This hyperpigmentation (darkening of the skin) occurs because the body produces excess amounts of a hormone called ACTH (adrenocorticotropic hormone) when trying to stimulate failing adrenal glands.^[2]

People who already have other autoimmune conditions should be especially alert to these symptoms. If you have type 1 diabetes, thyroid problems, vitiligo, or pernicious anemia, your risk of developing primary adrenal insufficiency is higher than in the general population. The body’s immune system sometimes attacks multiple organs, so having one autoimmune disease increases your chances of developing another.^[2]

Salt cravings are another unusual symptom that should prompt medical attention. People with primary adrenal insufficiency often find themselves desperately wanting salty foods because their bodies are losing too much sodium. This happens because the adrenal glands are not producing enough aldosterone, a hormone that helps regulate salt and water balance in the body.^[3]

The disease affects people of all ages, though it most commonly appears in adults between 30 and 50 years old. In the United States, it affects approximately 1 in 100,000 people, making it quite rare. However, this rarity can work against patients, as doctors may not immediately consider it when evaluating symptoms.^[2]

⚠️ Important

If you experience sudden severe symptoms such as extreme weakness, severe abdominal pain, confusion, very low blood pressure, or loss of consciousness, seek emergency medical care immediately. These could be signs of an adrenal crisis, a life-threatening emergency that requires immediate treatment with intravenous medications. Do not wait to see if symptoms improve on their own.

Classic Diagnostic Methods Used to Identify Primary Adrenal Insufficiency

When a doctor suspects you might have adrenal insufficiency based on your symptoms and medical history, the first step is usually measuring your blood cortisol level early in the morning. This timing matters because cortisol levels naturally fluctuate throughout the day, with the highest levels normally occurring in the morning. If your early morning cortisol level is very low, it strongly suggests adrenal insufficiency. However, if the result falls into an uncertain range, further testing is needed.^[4]

The definitive test for confirming adrenal insufficiency is called a cosyntropin stimulation test, also known as an ACTH stimulation test. During this procedure, medical staff will first draw a blood sample to measure your baseline cortisol level. Then they inject a synthetic version of ACTH called cosyntropin into your vein or muscle. This medication normally tells healthy adrenal glands to produce cortisol. After the injection, they draw blood samples again after 30 and 60 minutes to see how your cortisol level responds.^[6]

In people with healthy adrenal glands, the cortisol level rises significantly after the cosyntropin injection. However, if you have primary adrenal insufficiency, your cortisol level will remain low because your damaged adrenal glands cannot respond to the stimulation, no matter how much ACTH signal they receive. This inability to produce cortisol even when directly stimulated confirms the diagnosis.^[8]

Once adrenal insufficiency is confirmed, the next crucial step is determining whether it is primary or secondary. This distinction is essential because the conditions require different treatments. To make this determination, doctors measure your ACTH level, ideally at the same time as an early morning cortisol measurement. In primary adrenal insufficiency, the ACTH level is elevated because your pituitary gland is working overtime trying to stimulate your failing adrenal glands. Think of it like someone pressing an elevator button repeatedly when the elevator is broken. In contrast, secondary adrenal insufficiency shows low ACTH levels because the problem lies in the pituitary gland itself, which is not sending enough signal.^[6]

Blood tests to check electrolyte levels are also important in the diagnostic process. People with primary adrenal insufficiency often have abnormally high potassium and low sodium levels in their blood. These imbalances occur because the adrenal glands are not producing enough aldosterone to regulate these minerals properly. Doctors also typically check blood glucose levels, as low blood sugar is common in this condition.^[5]

To understand what caused the adrenal gland damage, doctors may order additional specialized tests. Blood tests can detect antibodies against adrenal tissue, which would indicate an autoimmune cause. In fact, antibodies against an enzyme called 21-hydroxylase are found in more than 90 percent of people with recent-onset autoimmune adrenal insufficiency. These antibodies can appear years before symptoms develop, which is why they are useful for diagnosis.^[11]

Imaging studies may also be part of the diagnostic workup. A CT scan (computed tomography scan) of the abdomen can show the size and structure of your adrenal glands. In autoimmune adrenal insufficiency, the glands are often small and atrophied. However, if the glands appear enlarged, this might suggest other causes such as infection, bleeding, or cancer spread to the adrenal glands. Sometimes doctors also order a chest X-ray to check for tuberculosis, which was historically the leading cause of primary adrenal insufficiency before autoimmune disease became more common.^[5]

Testing for other autoimmune conditions is often recommended because people with autoimmune adrenal insufficiency frequently develop additional autoimmune diseases. Your doctor may check your thyroid function, screen for diabetes, and test for other antibodies associated with autoimmune conditions. Up to 50 percent of people with autoimmune adrenal insufficiency will develop another autoimmune disorder during their lifetime.^[11]

Diagnostics for Clinical Trial Qualification

When researchers design clinical trials for primary adrenal insufficiency, they use very specific diagnostic criteria to ensure they are studying the right patients. These standardized testing approaches help guarantee that trial results are reliable and that different studies can be compared accurately.

For enrollment in clinical trials, participants must have documented evidence of primary adrenal insufficiency confirmed through the cosyntropin stimulation test. Researchers typically require that the peak cortisol level after stimulation falls below a specific threshold, often less than 18 micrograms per deciliter, though the exact cutoff may vary between studies. This objective measurement ensures that only people with true adrenal insufficiency participate in the trial.^[10]

Clinical trial protocols also require measurement of ACTH levels to confirm that the condition is primary rather than secondary. An ACTH level above the normal range, measured at the same time as a low cortisol level, provides this confirmation. Some trials may also measure plasma renin activity, which is typically elevated in primary adrenal insufficiency when aldosterone production is inadequate.^[13]

Researchers often screen for the underlying cause of adrenal insufficiency by testing for 21-hydroxylase antibodies. This helps identify participants with autoimmune disease versus other causes. Some trials may specifically focus on autoimmune adrenal insufficiency, so antibody testing becomes an essential inclusion criterion. Other trials might exclude people with certain causes to create more homogeneous study groups.^[10]

Blood tests checking electrolyte levels, particularly sodium and potassium, are standard in trial screening. These baseline measurements help researchers understand the severity of mineralocorticoid deficiency and monitor changes during the study. Some trials may also measure blood glucose levels and hemoglobin A1c to assess glucose metabolism and screen for diabetes.

Imaging studies such as CT scans of the adrenal glands may be required to exclude other conditions or to document the appearance of the adrenal glands at baseline. This becomes especially important in trials studying new treatments that might affect adrenal gland size or structure over time.

Clinical trials typically exclude people who have conditions that would make participation unsafe or confuse the study results. For example, people who have had recent major surgery, those taking certain medications that interfere with hormone measurements, or individuals with severe heart, kidney, or liver disease might not qualify. Pregnancy testing is usually required for women of childbearing age because many trial medications have not been proven safe during pregnancy.^[10]

⚠️ Important

If you are interested in participating in a clinical trial for primary adrenal insufficiency, work closely with your endocrinologist to ensure you meet the eligibility criteria. Bring copies of all your previous diagnostic test results to save time and avoid repeating uncomfortable procedures. Your doctor can help you understand whether a particular trial might be appropriate for your specific situation.

Prognosis and Survival Rate

Prognosis

With proper treatment, people with primary adrenal insufficiency can expect to live a normal, active life. The prognosis is generally very good when patients receive appropriate hormone replacement therapy and learn to manage their condition effectively. However, without treatment, primary adrenal insufficiency is life-threatening and can lead to severe complications or death.^[1]

The key to a positive outcome lies in consistent daily medication and patient education. People who understand their condition, take their prescribed hormones regularly, and know when to adjust their doses during illness or stress typically do very well. They can work, exercise, travel, and participate in most normal activities without significant limitations.^[7]

The most serious risk for people with primary adrenal insufficiency is an adrenal crisis, which occurs when hormone levels drop dangerously low during times of physical stress such as infection, injury, or surgery. These crises can be triggered by situations like severe illness, accidents, or failure to take medications. However, adrenal crises can be prevented with proper education about increasing medication doses during stress and having emergency injection kits available. When properly managed, the risk of crisis is significantly reduced.^[2]

Over the long term, some studies suggest that people with primary adrenal insufficiency may have a slightly increased risk of cardiovascular disease and osteoporosis compared to the general population. Regular monitoring and maintaining the lowest effective dose of replacement hormones helps minimize these risks. Following up regularly with an endocrinologist allows for adjustment of treatment to avoid both under-replacement and over-replacement of hormones, both of which can cause problems.^[6]

Survival rate

Specific survival rate statistics for primary adrenal insufficiency in the modern era are not extensively reported in the available medical literature. However, the condition is no longer considered to significantly reduce life expectancy when properly diagnosed and treated. Before effective hormone replacement therapy became available in the 1950s, Addison’s disease was uniformly fatal. Today, with appropriate treatment, people with this condition can achieve a normal life expectancy.^[1]

The mortality risk that does exist primarily comes from adrenal crises, which remain a medical emergency even in the current era. Studies have shown that patients who experience adrenal crises face serious risks if not treated immediately with intravenous corticosteroids and fluids. However, with prompt emergency treatment, most people recover fully from these episodes. The emphasis in modern care is on crisis prevention through patient education and appropriate stress-dose management.^[7]

#1 Clinical Trials Search in Europe